{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T09:50:39Z","timestamp":1762249839839,"version":"3.41.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To identify baseline morphological predictors of lesion shrinkage in eyes with myopic choroidal neovascularization (mCNV) treated with anti-vascular endothelial growth factor.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This retrospective study included 46 eyes (41 consecutive patients) with active mCNV receiving anti\u2013vascular endothelial growth factor treatment. Optical coherence tomography angiography was performed at baseline and 1 year after treatment. Quantitative features were obtained from optical coherence tomography angiography images using AngioTool software. Eyes were classified as \u201chigh shrinkage\u201d or \u201clow shrinkage\u201d according to the median relative change in lesion area. Baseline quantitative morphological features associated with mCNV shrinkage were identified in univariate and multivariate analyses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The mCNV area was significantly smaller after 1 year (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.013), with a median relative change of \u221216.5%. The relative change in mCNV area was \u221248.3% in high-shrinkage eyes (n = 23) and \u22125.2% in low-shrinkage eyes (n = 23). High-shrinkage eyes had a smaller mCNV area (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.013), shorter total vessel length (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.023), and higher end point density (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). Multivariate analysis showed significant associations of high shrinkage with end point density (\u03b2 = \u22120.037, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.043) and previous anti\u2013vascular endothelial growth factor treatment (\u03b2 = 0.216, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.029).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Morphological features of neovascularization detected by optical coherence tomography angiography can predict lesion shrinkage in eyes with mCNV receiving anti\u2013vascular endothelial growth factor therapy. Higher end point density contributed to shrinkage, particularly of treatment-naive lesions.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000003526","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T22:01:38Z","timestamp":1653084098000},"page":"1665-1672","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["PREDICTING LESION SHRINKAGE IN EYES WITH MYOPIC CHOROIDAL NEOVASCULARIZATION FROM FEATURES ON OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY"],"prefix":"10.1097","volume":"42","author":[{"given":"Jing","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China; and"},{"name":"Graduate School of Peking Union Medical College, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobing","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China; and"},{"name":"Graduate School of Peking Union Medical College, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250607","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ajo.2013.08.010","article-title":"Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review","volume":"157","author":"Wong","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"R2-20250607","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0161-6420(96)30515-0","article-title":"Etiology of choroidal neovascularization in young patients","volume":"103","author":"Cohen","year":"1996","journal-title":"Ophthalmology"},{"key":"R3-20250607","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0161-6420(03)00461-5","article-title":"Myopic choroidal neovascularization: a 10-year follow-up","volume":"110","author":"Yoshida","year":"2003","journal-title":"Ophthalmology"},{"key":"R4-20250607","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.preteyeres.2017.10.005","article-title":"Diagnosis and treatment guideline for myopic choroidal neovascularization due to pathologic myopia","volume":"63","author":"Ohno-Matsui","year":"2018","journal-title":"Prog Retin Eye Res"},{"key":"R5-20250607","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.ophtha.2015.01.025","article-title":"Intravitreal aflibercept injection in patients with myopic choroidal neovascularization: the MYRROR study","volume":"122","author":"Ikuno","year":"2015","journal-title":"Ophthalmology"},{"key":"R6-20250607","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ophtha.2013.10.023","article-title":"RADIANCE: a randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia","volume":"121","author":"Wolf","year":"2014","journal-title":"Ophthalmology"},{"key":"R7-20250607","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1097\/IAE.0000000000000766","article-title":"Optical coherence tomography angiography versus traditional multimodal imaging IN assessing the activity OF exudative age-related macular degeneration: a new diagnostic challenge","volume":"35","author":"Coscas","year":"2015","journal-title":"Retina"},{"key":"R8-20250607","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ophtha.2015.01.029","article-title":"Spectral-domain optical coherence tomography angiography of choroidal neovascularization","volume":"122","author":"de Carlo","year":"2015","journal-title":"Ophthalmology"},{"key":"R9-20250607","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ajo.2016.03.009","article-title":"Detection of myopic choroidal neovascularization using optical coherence tomography angiography","volume":"165","author":"Miyata","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"R10-20250607","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00417-018-04205-x","article-title":"Vascular remodeling of choroidal neovascularization in older myopic patients treated with ranibizumab","volume":"257","author":"Cohen","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R11-20250607","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1136\/bjophthalmol-2016-309162","article-title":"Optical coherence tomography angiography of myopic choroidal neovascularisation","volume":"101","author":"Querques","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"R12-20250607","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1097\/IAE.0000000000001456","article-title":"Neovascularization secondary to high myopia imaged BY optical coherence tomography angiography","volume":"37","author":"Bruy\u00e8re","year":"2017","journal-title":"Retina"},{"key":"R13-20250607","doi-asserted-by":"crossref","first-page":"657772","DOI":"10.3389\/fmed.2021.657772","article-title":"Optical coherence tomography angiography-based quantitative assessment of morphologic changes in active myopic choroidal neovascularization during anti-vascular endothelial growth factor therapy","volume":"8","author":"Wang","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R14-20250607","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1007\/s00417-021-05270-5","article-title":"Using optical coherence tomography angiography to guide myopic choroidal neovascularization treatment: a 3-year follow-up study","volume":"259","author":"Ueda-Consolvo","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R15-20250607","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/IAE.0000000000002005","article-title":"Application OF optical coherence tomography angiography to assess anti-vascular endothelial growth factor therapy IN myopic choroidal neovascularization","volume":"39","author":"Cheng","year":"2019","journal-title":"Retina"},{"key":"R16-20250607","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000504755","article-title":"Microvasculature changes of myopic choroidal neovascularization and the predictive value of feeder vessel disappearance after ranibizumab treatment revealed using optical coherence tomography angiography","volume":"243","author":"Giorno","year":"2020","journal-title":"Ophthalmologica"},{"key":"R17-20250607","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.ajo.2013.08.002","article-title":"Prognostic factors of eyes with na\u00efve subfoveal myopic choroidal neovascularization after intravitreal bevacizumab","volume":"156","author":"Yang","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"R18-20250607","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/IAE.0b013e318227aa09","article-title":"Prognostic factors for visual outcome after intravitreal anti-VEGF injection for naive myopic choroidal neovascularization","volume":"32","author":"Yoon","year":"2012","journal-title":"Retina"},{"key":"R19-20250607","doi-asserted-by":"crossref","first-page":"e27385","DOI":"10.1371\/journal.pone.0027385","article-title":"A computational tool for quantitative analysis of vascular networks","volume":"6","author":"Zudaire","year":"2011","journal-title":"PLoS One"},{"key":"R20-20250607","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12886-021-02088-x","article-title":"Result of intravitreal aflibercept injection for myopic choroidal neovascularization","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Ophthalmol"},{"key":"R21-20250607","first-page":"121","article-title":"Arteriogenesis versus angiogenesis: two mechanisms of vessel growth","volume":"14","author":"Buschmann","year":"1999","journal-title":"News Physiol Sci"},{"key":"R22-20250607","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1582-4934.2006.tb00290.x","article-title":"Arteriogenesis versus angiogenesis: similarities and differences","volume":"10","author":"Heil","year":"2006","journal-title":"J Cel Mol Med"},{"key":"R23-20250607","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ajo.2015.04.012","article-title":"Optical coherence tomography angiography signs of vascular abnormalization with antiangiogenic therapy for choroidal neovascularization","volume":"160","author":"Spaide","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"R24-20250607","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000487611","article-title":"Optical coherence tomography angiography to quantify choroidal neovascularization in response to aflibercept","volume":"240","author":"Takeuchi","year":"2018","journal-title":"Ophthalmologica"},{"key":"R25-20250607","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1097\/IAE.0000000000000879","article-title":"Longitudinal optical coherence tomography-angiography study OF type 2 naive choroidal neovascularization early response after treatment","volume":"35","author":"Lumbroso","year":"2015","journal-title":"Retina"},{"key":"R26-20250607","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1097\/IAE.0000000000000846","article-title":"Optical coherence tomography angiography OF time course OF choroidal neovascularization IN response to anti-angiogenic treatment","volume":"35","author":"Huang","year":"2015","journal-title":"Retina"},{"key":"R27-20250607","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ajo.2020.01.012","article-title":"OCT angiography features of neovascularization as predictive factors for frequent recurrence in age-related macular degeneration","volume":"213","author":"Choi","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"R28-20250607","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s12886-018-0992-y","article-title":"The repeatability of superficial retinal vessel density measurements in eyes with long axial length using optical coherence tomography angiography","volume":"18","author":"Li","year":"2018","journal-title":"BMC Ophthalmol"},{"key":"R29-20250607","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1167\/iovs.17-21551","article-title":"Axial length variation impacts on superficial retinal vessel density and foveal avascular zone area measurements using optical coherence tomography angiography","volume":"58","author":"Sampson","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003526","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T18:00:43Z","timestamp":1749319243000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000003526","relation":{},"ISSN":["0275-004X"],"issn-type":[{"type":"print","value":"0275-004X"}],"subject":[],"published":{"date-parts":[[2022,9]]}}}